(b)(4).Other: tga device incident report reference no (b)(4); submitted to tga (therapeutic goods administration) by a healthcare professional/user.The complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
|
It was reported to boston scientific corporation that an obtryx ii system - halo was implanted into the patient during a procedure performed on (b)(6) 2016.According to the complainant, following the implantation, the patient experienced chest pains, hospitalization, multiple pneumonia and pleurisy (no bacteria detected), chronic productive cough leading to upper respiratory dysfunction, chronic back and buttocks pain and bladder leakage while walking.The patient also experienced autoimmune symptoms including chronic fatigue, joint pain and stiffness, vision disturbance, memory loss, headaches, and passing out.The patient initially needed to reduce working hours to 3 hours a day but eventually has to permanently leave job.Subsequently, the patient underwent mesh removal on (b)(6) 2018.Boston scientific has been unable to obtain additional information regarding the event to date.
|